Business

Congestion has affected several major ports, including Kandla, Mundra, Jawaharlal Nehru Port (Nhava Sheva) and Chennai. Industry officials said that the situation has been aggravated by the rerouting of vessels due to geopolitical tensions.

On Monday, the Houthis announced a naval blockade on Saudi Arabia, potentially opening another front in the US-Israeli conflict with Iran and increasing risks to global energy supplies and international trade beyond the Gulf region.

Pharmaceutical stocks faced pressure after US President Trump unveiled a phased tariff plan for imported generic medicines. This plan introduces steep duties on generic drugs after a two-year tariff-free window. Indian drugmakers are reassessing supply chains and investment plans due to potential future impacts. Companies without US manufacturing presence may face significantly altered economics. The

The Indian rupee opened lower on Wednesday, facing pressure from rising crude oil prices. Geopolitical tensions and demand for safe-haven assets also weighed on the domestic currency. The Reserve Bank of India’s measures are helping to cushion the rupee’s decline. Meanwhile, Indian stock markets experienced a downturn in early trade. Foreign institutional investors remained net

Asian markets opened higher, mirroring Wall Street’s gains as technology stocks rebounded. Japan, South Korea, and Taiwan led the advance, while China also saw gains. Oil prices continued to climb due to threats in the Red Sea region. US markets closed higher overnight, with semiconductor shares driving the upward movement. Investor focus now shifts to

Donald Trump announced phased tariffs on imported generic medicines starting August 2026. These tariffs will gradually increase to 200 percent over three years. This policy aims to reshore pharmaceutical production back into America. India, a major supplier of affordable generics, faces significant impact from these changes. The move adds uncertainty to ongoing bilateral trade agreement.